| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $262.6M | -0.3% |
| R&D Expense | $285.2M | -18.1% |
| SG&A Expense | $95.9M | -42.0% |
| Operating Income | -$118.5M | +52.6% |
| Pre-tax Income | -$80.5M | +59.4% |
| Income Tax | $300K | -50.0% |
| Net Income | -$80.8M | +59.4% |
| EPS (Basic) | -$1.14 | +58.8% |
| EPS (Diluted) | -$1.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.9M | +42.2% |
| Short-term Investments | $542.5M | -42.2% |
| Accounts Receivable | $1.0M | -82.5% |
| Current Assets | $700.7M | -34.3% |
| Total Assets | $717.9M | -34.2% |
| Current Liabilities | $142.5M | -38.0% |
| Long-term Debt | $600K | -25.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$273.8M | -5.6% |
| Capital Expenditures | $1.9M | +5.6% |
| Investing Cash Flow | $407.6M | +1074.6% |
| Financing Cash Flow | -$91.4M | -1257.0% |
| Free Cash Flow | -$275.7M | -5.6% |
| +58.8% |
| Total Liabilities |
| $284.0M |
| -46.4% |
| Stockholders' Equity | $433.9M | -22.8% |